BLSM
BlossomHill Therapeutics, Inc.
Set alert
13.75 USD -1.46 -9.60%
13.51 Day range 16.40
13.75 52-week range 26.82
- YTD
- -14.06%
- 1 year
- -14.06%
- Open
- 16.40
- Prev close
- 15.21
- Mkt cap
- 437.04M
- Vol
- 156.30K
- Avg vol
- 227.95K
- EPS
- -4.70
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 13.51
- High
- 16.40
Financial health
FMP rating
C2 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 2
Valuation
P/E -7.7×
FY 2024 5y median -11.4× FY 2025
P/S 0.0×
FY 2024 5y median 0.0× FY 2025
P/B -3.5×
FY 2024 5y median -5.0× FY 2025
P/FCF -9.7×
FY 2024 5y median -12.2× FY 2025
EV/EBITDA -5.5×
FY 2024 5y median -7.8× FY 2025
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2025
FCF Yield -10.3%
FY 2024 5y median -8.5% FY 2025
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2025
ROE 46.0%
FY 2024 5y median 44.0% FY 2025
ROIC -43.4%
FY 2024 5y median -39.8% FY 2025
ROA -37.2%
FY 2024 5y median -33.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2025
Operating Income -75.9%
FY 2024 FY 2025
EPS (diluted) -96.2%
FY 2024 FY 2025
Free Cash Flow -52.3%
FY 2024 FY 2025
Financial Health
Current Ratio 9.0×
FY 2024 5y median 12.2× FY 2025
Quick Ratio 9.0×
FY 2024 5y median 12.2× FY 2025
Debt / Equity -0.2×
FY 2024 5y median -0.1× FY 2025
Net Debt / EBITDA 1.8×
FY 2024 5y median 2.3× FY 2025
Interest Coverage 0.0×
FY 2024 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31